Sun Yueying, Sun Yuanyuan, Tian Weimin, Liu Chenghui, Gao Kejian, Li Zhengping
Key Laboratory of Applied Surface and Colloid Chemistry , Ministry of Education , Key Laboratory of Analytical Chemistry for Life Science of Shaanxi Province , School of Chemistry and Chemical Engineering , Shaanxi Normal University , Xi'an 710062 , Shaanxi Province , P. R. China . Email:
Chem Sci. 2017 Dec 11;9(5):1344-1351. doi: 10.1039/c7sc04975g. eCollection 2018 Feb 7.
Sensitive and accurate detection of site-specific DNA methylation is of critical significance for early diagnosis of human diseases, especially cancers. Herein, for the first time we employ a novel methylation-dependent restriction endonuclease GlaI to detect site-specific DNA methylation in a highly specific and sensitive way by coupling with isothermal exponential amplification reaction (EXPAR). GlaI can only cut the methylated target site with excellent selectivity but leave the unmethylated DNA intact. Then the newly exposed end fragments of methylated DNA can trigger EXPAR for highly efficient signal amplification while the intact unmethylated DNA will not initiate EXPAR at all. As such, only the methylated DNA is quantitatively and faithfully reflected by the real-time fluorescence signal of the GlaI-EXPAR system, and the potential false positive interference from unmethylated DNA can be effectively eliminated. Therefore, by integrating the unique features of GlaI for highly specific methylation discrimination and EXPAR for rapid and powerful signal amplification, the elegant GlaI-EXPAR assay allows the direct quantification of methylated DNA with ultrahigh sensitivity and accuracy. The detection limit of methylated DNA target has been pushed down to the aM level and the whole detection process of GlaI-EXPAR can be accomplished within a short time of 2 h. More importantly, ultrahigh specificity is achieved and as low as 0.01% methylated DNA can be clearly identified in the presence of a large excess of unmethylated DNA. This GlaI-EXPAR is also demonstrated to be capable of determining site-specific DNA methylations in real genomic DNA samples. Sharing the distinct advantages of ultrahigh sensitivity, outstanding specificity and facile operation, this new GlaI-EXPAR strategy may provide a robust and reliable platform for the detection of site-specific DNA methylations with low abundances.
灵敏且准确地检测位点特异性DNA甲基化对于人类疾病尤其是癌症的早期诊断至关重要。在此,我们首次采用一种新型的甲基化依赖性限制性内切酶GlaI,通过与等温指数扩增反应(EXPAR)耦合,以高度特异且灵敏的方式检测位点特异性DNA甲基化。GlaI仅能以优异的选择性切割甲基化的靶位点,而使未甲基化的DNA保持完整。然后,甲基化DNA新暴露的末端片段可触发EXPAR进行高效信号放大,而完整的未甲基化DNA根本不会启动EXPAR。因此,只有甲基化DNA通过GlaI - EXPAR系统的实时荧光信号得到定量且如实反映,并且可以有效消除来自未甲基化DNA的潜在假阳性干扰。因此,通过整合GlaI用于高度特异性甲基化识别的独特特性以及EXPAR用于快速且强大的信号放大的特性,精巧的GlaI - EXPAR检测法能够以超高的灵敏度和准确性直接定量甲基化DNA。甲基化DNA靶标的检测限已降至aM水平,并且GlaI - EXPAR的整个检测过程可在短短2小时内完成。更重要的是,实现了超高特异性,在存在大量过量未甲基化DNA的情况下,低至0.01%的甲基化DNA也能被清晰识别。这种GlaI - EXPAR还被证明能够确定真实基因组DNA样本中的位点特异性DNA甲基化。这种新的GlaI - EXPAR策略具有超高灵敏度、出色特异性和操作简便的独特优势,可能为检测低丰度位点特异性DNA甲基化提供一个强大且可靠的平台。